Literature DB >> 24934182

CHRNA5 variants moderate the effect of nicotine deprivation on a neural index of cognitive control.

D E Evans1, D A MacQueen, K G Jentink, J Y Park, H-Y Lin, D J Drobes.   

Abstract

Individuals with reduced attention and memory cognitive control-related processes may be motivated to smoke as a result of the cognitive enhancing effects of nicotine. Further, nicotine deprivation-induced reductions in cognitive control may negatively reinforce smoking. Minor allele carriers at rs16969968 in the nicotinic acetylcholine receptor α5 subunit gene (CHRNA5) have been shown to exhibit both reduced cognitive control and greater nicotine dependence. It is therefore of interest to see if variants in this gene moderate the influence of nicotine deprivation on cognitive control. P3b and P3a components of the event-related brain potential waveform evoked by a three-stimulus visual oddball task are widely viewed as positive indices of cognitive control-related processes. We tested the hypothesis that individuals possessing at least one minor allele at rs16969968 in CHRNA5 would show greater nicotine deprivation-induced reductions in P3b and P3a amplitude. The sample included 72 non-Hispanic, Caucasian heavy smokers (54 men and 18 women) with a mean age of 36.11 years (SD = 11.57). Participants completed the visual oddball task during counterbalanced nicotine and placebo smoking sessions. Findings indicated that rs16969968 status did not moderate nicotine effects on P3b or P3a, whereas variation in other CHRNA5 polymorphisms, which are not as well characterized and are not in linkage disequilibrium with rs16969968, predicted nicotine deprivation-induced reduction of P3a amplitude: rs588765 (F1,68 = 7.74, P = 0.007) and rs17408276 (F1,67 = 7.34, P = 0.009). Findings are interpreted in the context of vulnerability alleles that may predict nicotine effects on cognitive control.
© 2014 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  CHRNA5; ERP; P300; P3a; P3b; cognitive control; genetics; nicotine; nicotinic acetylcholine; rs16969968; rs588765; smoking

Mesh:

Substances:

Year:  2014        PMID: 24934182      PMCID: PMC4178975          DOI: 10.1111/gbb.12151

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  15 in total

1.  Development and validation of the Wisconsin Smoking Withdrawal Scale.

Authors:  S K Welsch; S S Smith; D W Wetter; D E Jorenby; M C Fiore; T B Baker
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

2.  P3a from visual stimuli: task difficulty effects.

Authors:  Galen F Hagen; James R Gatherwright; Brian A Lopez; John Polich
Journal:  Int J Psychophysiol       Date:  2005-10-25       Impact factor: 2.997

Review 3.  Updating P300: an integrative theory of P3a and P3b.

Authors:  John Polich
Journal:  Clin Neurophysiol       Date:  2007-06-18       Impact factor: 3.708

Review 4.  Neuropsychology and neuropharmacology of P3a and P3b.

Authors:  John Polich; José R Criado
Journal:  Int J Psychophysiol       Date:  2006-02-28       Impact factor: 2.997

5.  Evaluating two-step PCA of ERP data with Geomin, Infomax, Oblimin, Promax, and Varimax rotations.

Authors:  Joseph Dien
Journal:  Psychophysiology       Date:  2009-09-15       Impact factor: 4.016

6.  Nicotine deprivation influences P300 markers of cognitive control.

Authors:  David E Evans; Nathan D Maxfield; Kate Janse Van Rensburg; Jason A Oliver; Kade G Jentink; David J Drobes
Journal:  Neuropsychopharmacology       Date:  2013-06-28       Impact factor: 7.853

7.  Acute negative affect relief from smoking depends on the affect situation and measure but not on nicotine.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Cynthia A Conklin; Michael A Sayette; Grace E Giedgowd
Journal:  Biol Psychiatry       Date:  2010-02-04       Impact factor: 13.382

Review 8.  Nicotine self-medication of cognitive-attentional processing.

Authors:  David E Evans; David J Drobes
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

9.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

10.  Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence.

Authors:  J C Wang; R Grucza; C Cruchaga; A L Hinrichs; S Bertelsen; J P Budde; L Fox; E Goldstein; O Reyes; N Saccone; S Saccone; X Xuei; K Bucholz; S Kuperman; J Nurnberger; J P Rice; M Schuckit; J Tischfield; V Hesselbrock; B Porjesz; H J Edenberg; L J Bierut; A M Goate
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

View more
  3 in total

1.  A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

Authors:  Kevin P Jensen; Elise E DeVito; Aryeh I Herman; Gerald W Valentine; Joel Gelernter; Mehmet Sofuoglu
Journal:  Neuropsychopharmacology       Date:  2015-05-07       Impact factor: 7.853

Review 2.  Genetics of addictive behavior: the example of nicotine dependence.

Authors:  Philip Gorwood; Yann Le Strat; Nicolas Ramoz
Journal:  Dialogues Clin Neurosci       Date:  2017-09       Impact factor: 5.986

3.  Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study.

Authors:  Gloria Pérez-Rubio; Luis Alberto López-Flores; Ana Paula Cupertino; Francisco Cartujano-Barrera; Luz Myriam Reynales-Shigematsu; Mariana Ramírez; Edward F Ellerbeck; Rosibel Rodríguez-Bolaños; Ramcés Falfan-Valencia
Journal:  Int J Environ Res Public Health       Date:  2021-06-19       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.